Research
The FARGO Study is Opening
The FARGO trial is opening soon. Find out what’s involved.
Read MoreThe SABR-PSC Study is Opening
The SABR-PSC Study is opening soon. Find out what’s involved.
Read MoreNew Clinical Trial Starting Called ELMWOOD
A new clinical trial is opening in the UK
Read MoreChemomab Therapeutics Receives FDA Fast Track Designation for CM-101 for the Treatment of PSC
Positive news for the SPRING trial investigational drug, CM-101
Read MoreMini Research Update Autumn 2023
PSC Support research – find out what we’ve been up to over the summer
Read MoreFirst Mission 2030 Research Announced
Read about the first Mission 2030 research studies funded by your donations
Read MoreItch Study Now Open at John Radcliffe Hospital Oxford
New site looking for volunteers in a study about itch
Read MorePositive Early Results From the INTEGRIS-PSC Clinical Trial
Early data from the INTEGRIS-PSC trial is promising
Read MoreVISTAS Itch Trial – Entry Age Now 16 Years
The age for entry onto this trial investigating a drug for itch has changed from 18 years to 16 years.
Read MoreQuality of Your PSC Care
ERN RARE-LIVER survey results have been published. Thank you to the 939 people with PSC who took part in this survey.
Read More